Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren-based versus amlodipine-based antihypertensive treatment in small abdominal aortic aneurysm
2011-000538-12Phase 4Active
- Sponsor
- VU University Medical Center
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aliskiren, amlodipine and hydrochlorothiazide in abdominal aortic aneurysm (AAA) and hypertension (HTN) (2 arms), sponsored by VU University Medical Center. Primary endpoint: Change from baseline in aneurysmal FDG uptake. Started May 2011; status: active.
02
Drugs
aliskirenamlodipinehydrochlorothiazide
03
Conditions
abdominal aortic aneurysm (AAA)hypertension (HTN)
Beyond the preview
Go deeper on 2011-000538-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000538-12.